These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10023642)
1. Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil. Jacob LP; Malhotra D; Chan L; Shapiro JI Am J Kidney Dis; 1999 Feb; 33(2):301-3. PubMed ID: 10023642 [TBL] [Abstract][Full Text] [Related]
2. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats. Morisaki I; Fukui N; Fujimori Y; Murakami J; Daikoku H; Amano A J Periodontol; 2000 Mar; 71(3):438-43. PubMed ID: 10776932 [TBL] [Abstract][Full Text] [Related]
3. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients. Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332 [TBL] [Abstract][Full Text] [Related]
4. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249 [TBL] [Abstract][Full Text] [Related]
5. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review. Soward AL; Vanhaleweyk GL; Serruys PW Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975 [TBL] [Abstract][Full Text] [Related]
6. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients]. Sperschneider H; Wagner C; Korn A; Christians U Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006 [TBL] [Abstract][Full Text] [Related]
7. Calcium ion blocking drugs. Resnekov L Compr Ther; 1982 Jul; 8(7):10-5. PubMed ID: 7116804 [No Abstract] [Full Text] [Related]
8. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats. Hammoud SH; Omar AG; Eid AA; El-Mas MM Toxicol Appl Pharmacol; 2017 Nov; 334():110-119. PubMed ID: 28899749 [TBL] [Abstract][Full Text] [Related]
10. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium. Schwinger RH; Böhm M; Erdmann E Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017 [TBL] [Abstract][Full Text] [Related]
11. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared. Nakaya H; Schwartz A; Millard RW Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222 [TBL] [Abstract][Full Text] [Related]
12. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522 [TBL] [Abstract][Full Text] [Related]
13. Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats. Whitehurst VE; Joseph X; Vick JA; Alleva FR; Zhang J; Balazs T Toxicology; 1996 Jun; 110(1-3):113-21. PubMed ID: 8658552 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris. Leon MB; Rosing DR; Bonow RO; Epstein SE Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518 [TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of intrathecal L-type calcium channel blockers on visceral and somatic stimuli in the rat. Hara K; Saito Y; Kirihara Y; Sakura S; Kosaka Y Anesth Analg; 1998 Aug; 87(2):382-7. PubMed ID: 9706935 [TBL] [Abstract][Full Text] [Related]
16. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue. Schwinger RH; Böhm M; Erdmann E J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911 [TBL] [Abstract][Full Text] [Related]
17. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175 [TBL] [Abstract][Full Text] [Related]
18. Effects of calcium antagonists on sympathetic nerve activity. Zsotér TT; Wolchinsky C Can J Cardiol; 1986; 2(4):256-60. PubMed ID: 3768782 [TBL] [Abstract][Full Text] [Related]
20. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation]. Pimenov LT; Ezhov AV; Churshin AD Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289 [No Abstract] [Full Text] [Related] [Next] [New Search]